Evidence map›Paper›PMID 33575582›Full record

ArticleNAR genomics and bioinformatics2020

Single-Cell Virtual Cytometer allows user-friendly and versatile analysis and visualization of multimodal single cell RNAseq datasets.

Frédéric Pont, Marie Tosolini, Qing Gao, Marion Perrier, Miguel Madrid-Mencía, Tse Shun Huang, Pierre Neuvial, Maha Ayyoub, Kristopher Nazor, Jean-Jacques Fournié

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Frédéric PontCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; ERL 5294 CNRS, Toulouse, France, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France, laboratoire d'Excellence Toulouse Cancer, TOUCAN.
Marie TosoliniCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; ERL 5294 CNRS, Toulouse, France, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France, laboratoire d'Excellence Toulouse Cancer, TOUCAN.
Qing GaoBiolegend, San Diego, CA 92121, USA.
Marion PerrierCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; ERL 5294 CNRS, Toulouse, France, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France, laboratoire d'Excellence Toulouse Cancer, TOUCAN.
Miguel Madrid-MencíaCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; ERL 5294 CNRS, Toulouse, France, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France, laboratoire d'Excellence Toulouse Cancer, TOUCAN.
Tse Shun HuangBiolegend, San Diego, CA 92121, USA.
Pierre NeuvialInstitut de Mathématiques de Toulouse, UMR 5219, Université de Toulouse, CNRS, UPS, F-31062 Toulouse, France.
Maha AyyoubCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; ERL 5294 CNRS, Toulouse, France, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France, laboratoire d'Excellence Toulouse Cancer, TOUCAN.
Kristopher NazorBiolegend, San Diego, CA 92121, USA.
Jean-Jacques FourniéCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, Toulouse, France; Université Toulouse III Paul-Sabatier, Toulouse, France; ERL 5294 CNRS, Toulouse, France, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse, France, laboratoire d'Excellence Toulouse Cancer, TOUCAN.
BioLegend (United States) · USCentre National de la Recherche Scientifique · FRInserm · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of single-cell transcriptomic technologies yields large datasets comprising multimodal informations, such as transcriptomes and immunophenotypes. Despite the current explosion of methods for pre-processing and integrating multimodal single-cell data, there is currently no user-friendly software to display easily and simultaneously both immunophenotype and transcriptome-based UMAP/t-SNE plots from the pre-processed data. Here, we introduce Single-Cell Virtual Cytometer, an open-source software for flow cytometry-like visualization and exploration of pre-processed multi-omics single cell datasets. Using an original CITE-seq dataset of PBMC from an healthy donor, we illustrate its use for the integrated analysis of transcriptomes and epitopes of functional maturation in human peripheral T lymphocytes. So this free and open-source algorithm constitutes a unique resource for biologists seeking for a user-friendly analytic tool for multimodal single cell datasets.

Identifiers

PMID33575582
PMCPMC7671361
OpenAlexW3019365805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.